Financials Zenicor Medical Systems AB
Equities
ZENI
SE0006343984
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.98 SEK | -1.32% |
|
-.--% | -6.88% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 115 | 82.29 | 69.32 | 167.4 | 115.5 | 28.87 |
Enterprise Value (EV) 1 | 111.9 | 86.39 | 75.88 | 177.9 | 132.8 | 41.74 |
P/E ratio | -42.5 x | -47.9 x | 48.6 x | 266 x | -66.1 x | -5.17 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 4.64 x | 3.33 x | 2.98 x | 6.45 x | 3.94 x | 0.89 x |
EV / Revenue | 4.51 x | 3.49 x | 3.26 x | 6.86 x | 4.53 x | 1.29 x |
EV / EBITDA | -47 x | -67.3 x | 41.2 x | 143 x | -184 x | -16.5 x |
EV / FCF | -13 x | -13.2 x | -25.1 x | -42.1 x | -21.6 x | -3.1 x |
FCF Yield | -7.71% | -7.6% | -3.98% | -2.38% | -4.64% | -32.3% |
Price to Book | 6.49 x | 5.15 x | 3.98 x | 9.27 x | 7.09 x | 0.94 x |
Nbr of stocks (in thousands) | 5,636 | 5,636 | 5,636 | 5,636 | 5,636 | 9,023 |
Reference price 2 | 20.40 | 14.60 | 12.30 | 29.70 | 20.50 | 3.200 |
Announcement Date | 29/04/19 | 24/04/20 | 27/04/21 | 03/05/22 | 20/04/23 | 22/04/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 24.79 | 24.74 | 23.26 | 25.94 | 29.31 | 32.26 |
EBITDA 1 | -2.381 | -1.284 | 1.843 | 1.243 | -0.7216 | -2.534 |
EBIT 1 | -2.468 | -1.373 | 1.788 | 1.214 | -0.7653 | -4.111 |
Operating Margin | -9.95% | -5.55% | 7.68% | 4.68% | -2.61% | -12.74% |
Earnings before Tax (EBT) 1 | -2.704 | -1.718 | 1.426 | 0.6288 | -1.747 | -5.588 |
Net income 1 | -2.704 | -1.718 | 1.426 | 0.6288 | -1.747 | -5.588 |
Net margin | -10.91% | -6.94% | 6.13% | 2.42% | -5.96% | -17.32% |
EPS 2 | -0.4798 | -0.3048 | 0.2529 | 0.1116 | -0.3100 | -0.6193 |
Free Cash Flow 1 | -8.626 | -6.566 | -3.019 | -4.228 | -6.156 | -13.48 |
FCF margin | -34.79% | -26.54% | -12.98% | -16.3% | -21.01% | -41.78% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 29/04/19 | 24/04/20 | 27/04/21 | 03/05/22 | 20/04/23 | 22/04/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | 4.1 | 6.56 | 10.5 | 17.3 | 12.9 |
Net Cash position 1 | 3.08 | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | -3.195 x | 3.559 x | 8.465 x | -23.91 x | -5.079 x |
Free Cash Flow 1 | -8.63 | -6.57 | -3.02 | -4.23 | -6.16 | -13.5 |
ROE (net income / shareholders' equity) | -26.3% | -10.2% | 8.53% | 3.55% | -10.2% | -23.8% |
ROA (Net income/ Total Assets) | -8.17% | -3.14% | 3.62% | 2.07% | -1.11% | -4.84% |
Assets 1 | 33.09 | 54.73 | 39.41 | 30.43 | 157.7 | 115.4 |
Book Value Per Share 2 | 3.140 | 2.840 | 3.090 | 3.200 | 2.890 | 3.390 |
Cash Flow per Share 2 | 1.120 | 0.4800 | 0.2100 | 0.1900 | 0.1000 | 0.3500 |
Capex 1 | 0.04 | 0.03 | 0.01 | 0.06 | 4.63 | 0.12 |
Capex / Sales | 0.17% | 0.14% | 0.05% | 0.23% | 15.79% | 0.36% |
Announcement Date | 29/04/19 | 24/04/20 | 27/04/21 | 03/05/22 | 20/04/23 | 22/04/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-6.88% | 2.53M | |
+1.10% | 207B | |
+3.80% | 181B | |
+29.15% | 155B | |
+31.82% | 112B | |
+1.98% | 64.42B | |
+18.35% | 54.38B | |
-1.86% | 47.43B | |
-9.03% | 37.17B | |
-1.29% | 34.81B |
- Stock Market
- Equities
- ZENI Stock
- Financials Zenicor Medical Systems AB